G-CSF and G-CSF Biosimilars Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
G-CSF y G-CSF biosimilares se utilizan principalmente para prevenir la neutropenia en pacientes con cáncer que reciben quimioterapia mielosupresora. G-CSF es el factor estimulante de colonias de granulocitos, que es una glicoproteína que estimula la médula ósea para que produzca células madre y granulocitos y luego los libera al torrente sanguíneo. Los dos biosimilares más comunes de G-CSF son filgrastim y pegfilgrastim. El uso medicinal de los biosimilares de G-CSF incluye la prevención de la neutropenia durante la quimioterapia, antes de la donación de sangre y durante el trasplante de células madre.
DINÁMICA DEL MERCADO
Los impulsores clave del mercado para el G-CSF y el mercado de biosimilares de G-CSF son la creciente prevalencia del cáncer y los trastornos metabólicos en todo el mundo. mundo junto con los crecientes efectos secundarios asociados con la quimioterapia y la inmunoterapia. Además, es probable que el aumento de la financiación de la investigación para el desarrollo de nuevas terapias impulse el crecimiento del mercado durante el período previsto. Además, se espera que varios otros enfoques emergentes para el tratamiento del cáncer, como la inmunoterapia, el trasplante de células madre y el trasplante de médula ósea, impulsen el crecimiento del mercado. Sin embargo, se espera que el estricto marco regulatorio y el alto costo del tratamiento limiten el crecimiento del mercado durante el período previsto.
ALCANCE DEL MERCADO
El "Mercado de G-CSF y G-CSF Biosimilares" es un estudio especializado y en profundidad de la industria farmacéutica con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de G-CSF y biosimilares de G-CSF con una segmentación detallada del mercado por tipo y aplicación. Se espera que el mercado de biosimilares de G-CSF y G-CSF sea testigo de un alto crecimiento durante el período de pronóstico. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores en el mercado de biosimilares de G-CSF y G-CSF y ofrece tendencias y oportunidades clave en el mercado.
SEGMENTACIÓN DEL MERCADO
El mercado de biosimilares de G-CSF y G-CSF está segmentado según el tipo y la aplicación. Según el tipo, el mercado se segmenta en hormona del crecimiento humano, eritropoyetina, anticuerpos monoclonales, interferón y factor estimulante de colonias de granulocitos. Y según la aplicación, el mercado se segmenta en trastornos sanguíneos, trastornos oncológicos, enfermedades crónicas y autoinmunes.
G-CSF and G-CSF Biosimilars Market: Strategic Insights
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Pfizer
- Novartis
- Roche Holding AG
- Merck and Co
- Sanofi
- Johnson and Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie Inc
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
- hormona de crecimiento humano
- eritropoyetina
- anticuerpos monoclonales
- insulina
- interferón
- factor estimulante de colonias de granulocitos
- trastornos de la sangre
- enfermedades oncológicas
- enfermedades crónicas y autoinmunes
- deficiencias de la hormona del crecimiento
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y un pronóstico del mercado de G-CSF y biosimilares de G-CSF en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico del año 2021 al 2031 con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y Sur y África. Centroamérica. El mercado de biosimilares de G-CSF y G-CSF de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 18 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región.
El informe analiza los factores que afectan el mercado de biosimilares de G-CSF y G-CSF tanto desde el lado de la demanda como de la oferta y evalúa más a fondo la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y Sur y Sur. Centroamérica luego de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el Mercado de G-CSF y Biosimilares de G-CSF en estas regiones.
ACTORES DEL MERCADO
El informe cubre desarrollos clave en las estrategias de crecimiento orgánico e inorgánico de los mercados de biosimilares de G-CSF y G-CSF. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones y asociaciones y asociaciones. colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado de G-CSF y G-CSF Biosimilars Market tendrán lucrativas oportunidades de crecimiento en el futuro con la creciente demanda del mercado de G-CSF y G-CSF Biosimilars en el mercado global. A continuación se menciona la lista de algunas empresas involucradas en el mercado de biosimilares de G-CSF y G-CSF.
El informe también incluye los perfiles de los actores clave en el mercado de biosimilares de G-CSF y G-CSF junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años, desarrollo clave en los últimos cinco años.
- • Pfizer • Novartis • Roche Holdings AG • Merck y compañía • Sanofi • Johnson y Johnson • Ciencias de Gilead • GlaxoSmithKline • AbbVie, Inc. • Amgen
El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.
G-CSF and G-CSF Biosimilars Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ XX million |
Market Size by | US$ XX Million |
Global CAGR | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Tipo
|
Regions and Countries Covered |
América del Norte
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Pfizer
2. Novartis
3. Roche Holding AG
4. Merck and Co
5. Sanofi
6. Johnson and Johnson
7. Gilead Science
8. GlaxoSmithKline
9. AbbVie Inc
10. Amgen
11. AstraZeneca
12. Bayer
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.